Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naïve Type 2 Diabetes
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Care
DOI: 10.2337/dc15-1736
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: type 2 diabetes, canagliflozin, extended-release metformin, SGLT2 inhibitors, combination therapy, monotherapy, initial treatment, HbA1c, glycemic control, weight loss, blood pressure, drug-naive patients, non-inferiority, dose comparison, body weight, fasting blood glucose, adverse events, hypoglycemia, urinary tract infection
Open Access status: closed
Funder: Janssen Research and Development
OpenAlex ID: W2278329651
